FDA Approved: TICAGRELOR — Original Application (Oryza Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the ticagrelor product from Oryza Pharmaceuticals, Inc. under its original application (ANDA 208508).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Stroke

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

ORIG AP for TICAGRELOR (TICAGRELOR)